Home › Cancer (all types) › NCT03809585

Observational Study of Iris Tumors

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria for tumor group:

* Eyes with diagnosis of melanotic or amelanotic iris tumors

Inclusion Criteria for healthy control group:

* Eyes without iris defects or lesions

Exclusion Criteria (both groups):

* Inability to give informed consent
* Inability to maintain stable fixation for OCT imaging
* Inability to commit to required study visits
* Eyes with concurrent retinal diseases, glaucoma, or conditions that in the opinion of the investigators might affect iris circulation
* Mature cataracts if found to limit visual potential to worse than 20/40

About the study

This is an observational study using OCT angiography to assist with tumor characterization in melanotic and amelanotic iris lesions. OCT angiography data from healthy eyes will be compared to eyes with various types of iris tumors.

Sponsor: Oregon Health and Science University · Participants: 100 · Started: Jun 20, 2018

Contact the study team

• Denzil Romfh, OD · Phone: 503-494-4351
• Humberto Martinez, COT · Phone: 503-494-7712

Official record on ClinicalTrials.gov — NCT03809585

Locations in the U.S.

Conditions

• Cancer (all types)
• Melanoma

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.